FDA Accuses Stem Cell Company of Illegal Marketing, Manufacturing Violations

The U.S. Food and Drug Administration has issued a warning to a San Diego-based stem cell company over what the agency alleges are illegal marketing practices and manufacturing violations. The FDA issued the warning to StemGenex Biologic Laboratories LLC of San Diego; its owner/manager, Rita Alexander; and laboratory and medical director Dr. Jenny Galloway. “We continue to see bad actors exploit the scientific promise of this field to mislead vulnerable patients into believing they’re being given safe, effective treatments,” FDA Commissioner Scott Gottlieb said in a news re...